MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-20-0011780
HTS Biopharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹6.71 Cr
▲ 7% YoY
Net profit · FY 2024
₹49.97 Lakh
Net margin 7.4%
EBITDA · FY 2024
₹88.93 Lakh
EBITDA margin 13.3%
Authorised capital
₹9 Lakh
Registered with MCA
Paid-up capital
₹9 Lakh
Issued & subscribed
Open charges
₹2 Cr
Secured borrowings
Company age
14 yrs
Est. 2012
Directors on board
3
As per MCA filings
About HTS Biopharma Private Limited
Data last updated:
HTS Biopharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 16 April 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2012PTC080323. Its GSTIN is 36AACCH9037P1Z0 (Telangana).
The company has an authorised share capital of ₹9 Lakh and a paid-up capital of ₹9 Lakh. It is led by directors including Srinivas Reddy Chaduvu and Surendar Velagapuri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No: 97 Aleap Industrial Estate Road No: 9 Pragathi Nagar Medchal – Malkajgiri, Hyderabad, Telangana, India – 500090.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.71 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹49.97 Lakh (net margin 7.4%) and EBITDA of ₹88.93 Lakh (EBITDA margin 13.3%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 9% over five years.
The company is associated with 1 brand: HTS Biopharma. As per MCA filings, the company has open charges of ₹2 Cr on record.
HTS Biopharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0011780). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website htsbiopharma.com.
Company details
CIN U24232TG2012PTC080323
Registration Number 080323
Incorporation Date 16 April 2012
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0011780
CIN history
HTS Biopharma has one previous CIN (Corporate Identification Number): U24232AP2012PTC080323. The current CIN is U24232TG2012PTC080323, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2012PTC080323 | Current |
| U24232AP2012PTC080323 | Previous |
Recognitions & Rankings of HTS Biopharma
Contact details
HTS Biopharma Private Limited's registered office is in Hyderabad, Telangana. Its website is htsbiopharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No: 97 Aleap Industrial Estate Road No: 9 Pragathi Nagar Medchal – Malkajgiri, Hyderabad, Telangana, India – 500090
- IndustryPharma, API Manufacturers
To see the full contact details of HTS Biopharma Private Limited, buy the company report.
Comprehensive company report
HTS Biopharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
HTS Biopharma operates one associated brand: HTS Biopharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures API impurities, reference standards, and offers custom synthesis services. | htsbiopharma.com |
Business activity
The main business activity of HTS Biopharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of HTS Biopharma Private Limited, buy the company report.
Financials of HTS Biopharma Private Limited
FY 2025 filings availableHTS Biopharma Private Limited reported revenue of ₹6.71 Cr (up 7% YoY) for FY 2024.
Revenue · FY 2024
₹6.71 Cr ▲ 7%
Net profit · FY 2024
₹49.97 Lakh margin 7.4%
EBITDA · FY 2024
₹88.93 Lakh margin 13.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 6%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▼ 2%
3 years · compounded
▼ 5%
5 years · compounded
▼ 1%
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 7% growth in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹88.93 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹49.97 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.3% | ||||
| Net Profit Margin | 7.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of HTS Biopharma Private Limited, buy the company report.
Board of directors of HTS Biopharma Private Limited
HTS Biopharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivas Reddy Chaduvu | Director | 20 Jan 2017 | 9 Years 9 Months | Current |
| Surendar Velagapuri Also directs: Synventia Pharma Private Limited | Director | 20 Jan 2017 | 9 Years 9 Months | Current |
| Neelima Veldi | Director | 21 Sep 2013 | 13 Years 1 Months | Current |
Peer comparison
HTS Biopharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (API Manufacturers, Biopharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dharoya Pharmaciuticales Pvt Ltd | ₹6.93 Cr (FY 2025) | -29.0% | Vadodara, Gujarat, India | |||
| Vindhya Pharma (India) Private Limited | ₹6.89 Cr (FY 2025) | -50.0% | Hyderabad, Telangana, India | |||
| Anant Pharmaceuticals Private Limited | ₹6.76 Cr (FY 2025) | 7.0% | Ambernath East, Maharashtra, India | |||
| HTS Biopharma Private Limitedthis company | ₹6.71 Cr (FY 2024) | ₹49.97 Lakh | 7.4% | 7.0% | Hyderabad, Telangana, India | |
| Abhinandan Rasayan Private Limited | ₹6.66 Cr (FY 2018) | -37.0% | Dombivli East, Maharashtra, India | |||
| Alchem Synthon Private Limited. | ₹6.53 Cr (FY 2025) | -17.0% | Thane, Maharashtra, India | |||
| Ravi Biolife Private Limited | ₹6.49 Cr (FY 2025) | 0.0% | Mumbai, Maharashtra, India | |||
| Healthgenic Chemicals Private Limited | ₹6.49 Cr (FY 2025) | -24.0% | Morbi, Gujarat, India |
To see the full peer comparison of HTS Biopharma Private Limited, buy the company report.
Auditor
HTS Biopharma Private Limited is audited by POTNURU AND ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| POTNURU AND ASSOCIATES | FY 2020 | 013007S |
Shareholding
The shareholding of HTS Biopharma Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of HTS Biopharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Mar 2021 | 100464593 | Others | ₹2 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving HTS Biopharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for HTS Biopharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
HTS Biopharma has 1 associated company. This group structure data is as of FY 2020. The table lists each entity with its relationship and holding.
1
Associated companies
GST
HTS Biopharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCH9037P1Z0 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of HTS Biopharma Private Limited, buy the company report.
Recent activity
HTS Biopharma Private Limited has 7 board changes on record since 2013: 3 appointments and 4 cessations. The latest: Rajeshwar Rao Kokkirala ceased to be Director on 21 Jan 2017.
AGM
Hts Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Hts Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 200.00 Lakh with Charge ID 100464593 was registered on 28 Mar 2021.
Ceased
Rajeshwar Rao Kokkirala ceased to be Director.
Appointed
Srinivas Reddy Chaduvu was appointed as Director.
Appointed
Surendar Velagapuri was appointed as Director.
Ceased
Srinivas Reddy Chaduvu ceased to be Director.
Ceased
Surendar Velagapuri ceased to be Director.
Ceased
Venu Gopal Veldi ceased to be Director.
Appointed
Neelima Veldi was appointed as Director.
Incorporation
16 Apr 2012
Hts Biopharma Private Limited was registered on 16 Apr 2012 with Roc Hyderabad & aged 14 years 6 months as per MCA records.
Frequently asked questions
HTS Biopharma is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 16 April 2012 (14+ years old) and is registered under CIN U24232TG2012PTC080323.
HTS Biopharma has 3 current directors:
- Srinivas Reddy Chaduvu - Director
- Surendar Velagapuri - Director
- Neelima Veldi - Director
The latest financial statements of HTS Biopharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of HTS Biopharma is 36AACCH9037P1Z0, registered in Telangana.
The CIN (Corporate Identification Number) of HTS Biopharma is U24232TG2012PTC080323. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
HTS Biopharma was incorporated on 16 April 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of HTS Biopharma by revenue are Dharoya Pharmaciuticales Pvt Ltd, Vindhya Pharma (India) Private Limited, Anant Pharmaceuticals Private Limited, Abhinandan Rasayan Private Limited, Alchem Synthon Private Limited. and 2 more, all in the Pharma industry (API Manufacturers, Biopharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rajeshwar Rao Kokkirala ceased to be Director on 21 Jan 2017. Srinivas Reddy Chaduvu was appointed as Director on 20 Jan 2017. Surendar Velagapuri was appointed as Director on 20 Jan 2017. HTS Biopharma has 7 board changes on record in total.
Yes, HTS Biopharma is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0011780).
HTS Biopharma can be reached through the website htsbiopharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of HTS Biopharma is at Plot No: 97 Aleap Industrial Estate Road No: 9 Pragathi Nagar Medchal – Malkajgiri, Hyderabad, Telangana, India – 500090.